Licia Grazzi, MD, Fondazione IRRCS Istituto Neurologico Carlo Besta, Milan, Italy, discusses the use of mindfulness in headache disorders and shares preliminary findings from a Phase III trial on mindfulness added to treatment as usual for patients with chronic migraine and medication overuse headache (MOH). In the clinical trial, patients were randomized to receive treatment as usual (TaU; structured withdrawal of overused drugs, patient education and pharmacological prophylaxis) or TaU and mindfulness. Preliminary results suggest that adding mindfulness-based sessions to TaU was feasible and showed short-term efficacy in treating patients with chronic migraine and MOH. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.